Daring to be extraordinary for you

At Galen, our purpose is to be of Extraordinary Service to our patients, healthcare professionals, partners, and the wider Galen family.

We promise to always go above and beyond to help meet our patients, suppliers and healthcare professionals needs, so we can benefit the health of all generations.

We are a privately owned pharmaceutical company established in 1968, with global headquarters in Craigavon, Northern Ireland.  We have commercial operations based in the UK and Europe, global partners in every continent and are positioned to distribute products worldwide.

Galen is the proud founding member of the Almac Group of world-class companies in the pharmaceutical and biotech sectors.  The Group is wholly owned by the McClay Foundation, whose overarching aim is to make a meaningful improvement and advancement in human health.

 

How can we help you?


We are committed to making a positive impact in everything we do, providing extraordinary service and care to you.

Our specialist teams offer their expertise to help you with your individual needs. Support includes:

  • Sales, marketing and launch excellence – we are comprehensively equipped to successfully champion your product.
  • Market access – Our highly skilled team are experts at generating a positive access environment for the products it promotes.
  • Regulatory affairs, pharmacovigilance and medical affairs – we have a team of dedicated professionals providing key services to support the commercialisation of your products.
  • We are positioned to distribute products across many global regions including the UK, the Republic of Ireland (ROI), the Nordics, Europe and the USA. Our impressive reach proves an attractive proposition to potential partners.

50+

Years of Experience

75+

Current products

25

LOCATIONS WORLDWIDE

 

Our Global Reach

Corporate Social Responsibility

The strategy and activities outlined within this report demonstrate our organisation’s current and future commitment to long-term corporate sustainability and positive corporate impact.

Our strategy aims to maximise our efficiencies and promote fair and sustainable business practices, while ensuring we continue to prioritise initiatives with the greatest impact on human health.

Looking forward, we are committed to measuring and expanding our strategy.

MAT-GAL-UKI-000222. DATE OF PREPARATION: June 2024.

Would you like to discuss how Galen can help you?

If you would like to explore how our expertise could add value to your product, or for an initial discussion about partnering with us, please contact our team.